Literature DB >> 15956599

Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.

J Ludovic Croxford1, Julie K Olson, Holly A Anger, Stephen D Miller.   

Abstract

Epidemiological studies indicate that infectious agents are important in the pathogenesis of multiple sclerosis (MS). Our previous reports showed that the infection of SJL mice with a nonpathogenic variant of Theiler's murine encephalomyelitis virus (TMEV) engineered to express a naturally occurring Haemophilus influenzae-encoded molecular mimic (HI574-586) of an immunodominant self-myelin proteolipid protein epitope (PLP139-151) induced a rapid-onset demyelinating disease associated with the activation of PLP139-151-specific Th1 responses. The current results extend our previous findings in four critical respects. We show that disease initiation by the H. influenzae mimic is prevented by tolerance to the self PLP139-151 epitope, definitively proving the occurrence of infection-induced molecular mimicry. We demonstrate that the H. influenzae mimic epitope can be processed from the flanking sequences within the native mimic protein. We show that the H. influenzae mimic epitope only induces an immunopathologic self-reactive Th1 response and subsequent clinical disease in the context of the TMEV infection and not when administered in complete Freund's adjuvant, indicating that molecular mimicry-induced disease initiation requires virus-activated innate immune signals. Lastly, we show that the infection of SJL mice with TMEV expressing the H. influenzae mimic can exacerbate a previously established nonprogressive autoimmune disease of the central nervous system. Collectively, these findings illustrate the evolving mechanisms by which virus infections may contribute to both the initiation and exacerbation of autoimmune diseases, and they have important implications for MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956599      PMCID: PMC1143754          DOI: 10.1128/JVI.79.13.8581-8590.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

2.  Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.

Authors:  M K Kennedy; L J Tan; M C Dal Canto; V K Tuohy; Z J Lu; J L Trotter; S D Miller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

3.  Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.

Authors:  J M Smyth; B J Sheahan; G J Atkins
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

4.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

5.  Clinical viral infections and multiple sclerosis.

Authors:  W A Sibley; C R Bamford; K Clark
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

6.  Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features.

Authors:  J F Kurtzke; K Hyllested
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

7.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

8.  Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.

Authors:  T Olsson; J Sun; J Hillert; B Höjeberg; H P Ekre; G Andersson; O Olerup; H Link
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

9.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 10.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more
  17 in total

Review 1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections.

Authors:  M T Getts; S D Miller
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

Review 3.  Antiviral immune responses: triggers of or triggered by autoimmunity?

Authors:  Christian Münz; Jan D Lünemann; Meghann Teague Getts; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

4.  Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.

Authors:  Kyong Hwa Park; Ekram Gad; Vivian Goodell; Yushe Dang; Thayer Wild; Doreen Higgins; Patty Fintak; Jennifer Childs; Corazon Dela Rosa; Mary L Disis
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

5.  Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.

Authors:  Juan A García-León; Carlos López-Gómez; Teresa Orpez-Zafra; Virginia Reyes-Garrido; Carmen Marín-Bañasco; Begoña Oliver-Martos; Oscar Fernández; Laura Leyva
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 6.  Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease.

Authors:  Emily M L Chastain; Stephen D Miller
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

7.  Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.

Authors:  Silvia S Borkosky; Corinna Whitley; Annette Kopp-Schneider; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 8.  Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Christine Riedhammer; Robert Weissert
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

9.  Humans have antibodies against a plant virus: evidence from tobacco mosaic virus.

Authors:  Ruolan Liu; Radhika A Vaishnav; Andrew M Roberts; Robert P Friedland
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Early IFNγ-Mediated and Late Perforin-Mediated Suppression of Pathogenic CD4 T Cell Responses Are Both Required for Inhibition of Demyelinating Disease by CNS-Specific Autoregulatory CD8 T Cells.

Authors:  Alexander W Boyden; Ashley A Brate; Nitin J Karandikar
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.